Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025)
Neogen (NEOG) posted Asset Writedowns and Impairment of $597.9 million for Q2 2025, up 28994.89% on a QoQ basis from $2.1 million in Q1 2025, and up 99550.0% year-over-year from N/an in Q2 2024.
Analysis
Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends
Neogen has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $597.9 million in Q2 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 99550.0% year-over-year to $597.9 million in Q2 2025; TTM through May 2026 was $600.0 million, a 0.02% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 178016.67% from the prior year.
- Asset Writedowns and Impairment was $597.9 million for Q2 2025 at Neogen, up from $2.1 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $597.9 million in Q2 2025, with the low at -$716000.0 in Q1 2024.
- Average Asset Writedowns and Impairment over 3 years is $120.1 million, with a median of $809000.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment decreased 25.83% in 2024, then surged 99550.0% in 2025.
- Over 3 years, Asset Writedowns and Impairment stood at $809000.0 in 2023, then dropped by 25.83% to $600000.0 in 2024, then soared by 99550.0% to $597.9 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $597.9 million (Q2 2025), $2.1 million (Q1 2025), and $600000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2025 | 597.90 Mn |
| Feb 28, 2025 | 2.06 Mn |
| May 31, 2024 | 600,000.00 |
| Feb 29, 2024 | -716,000.00 |
| May 31, 2023 | 809,000.00 |